0.3221
6.44%
0.0195
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché BMRA Giù?
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$0.3026
Aprire:
$0.3026
Volume 24 ore:
8.05M
Relative Volume:
14.51
Capitalizzazione di mercato:
$5.42M
Reddito:
$5.41M
Utile/perdita netta:
$-6.35M
Rapporto P/E:
-0.6442
EPS:
-0.5
Flusso di cassa netto:
$-5.39M
1 W Prestazione:
-0.68%
1M Prestazione:
+9.19%
6M Prestazione:
-48.55%
1 anno Prestazione:
-64.60%
Biomerica Inc Stock (BMRA) Company Profile
Nome
Biomerica Inc
Settore
Industria
Telefono
(949) 379-2875
Indirizzo
17571 VON KARMAN AVENUE, IRVINE, CA
Confronta BMRA con altri titoli
Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
---|---|---|---|---|---|---|
BMRA
Biomerica Inc
|
0.3221 | 5.42M | 5.41M | -6.35M | -5.39M | -0.50 |
ABT
Abbott Laboratories
|
118.95 | 208.18B | 41.22B | 5.77B | 6.49B | 2.94 |
SYK
Stryker Corp
|
388.14 | 148.70B | 21.97B | 3.59B | 3.21B | 6.74 |
BSX
Boston Scientific Corp
|
90.75 | 133.32B | 15.91B | 1.79B | 1.89B | 0.82 |
MDT
Medtronic Plc
|
86.27 | 111.27B | 33.00B | 4.29B | 5.50B | 2.71 |
EW
Edwards Lifesciences Corp
|
72.07 | 42.66B | 6.60B | 4.16B | 490.10M | 2.34 |
Biomerica Inc Stock (BMRA) Upgrades & Downgrades
Data | Azione | Analista | Modifica della valutazione |
---|---|---|---|
2020-11-10 | Iniziato | Colliers Securities | Buy |
2018-01-04 | Iniziato | B. Riley FBR, Inc. | Buy |
Biomerica Inc Borsa (BMRA) Ultime notizie
Biomerica secures patents for GI treatments in Europe By Investing.com - Investing.com South Africa
Biomerica secures patents for GI treatments in Europe - Investing.com India
Biomerica Secures Three Key International Patents for inFoods® Technology to Address GERD, Crohn's Disease, and Ulcerative Colitis - The Manila Times
Biomerica Secures Major European Patents for $8B+ Disease Treatment Technology | BMRA Stock News - StockTitan
Granahan Investment Management Reduces Stake in Biomerica Inc - GuruFocus.com
Biomerica granted Nasdaq compliance extension By Investing.com - Investing.com South Africa
Biomerica granted Nasdaq compliance extension - Investing.com India
Nasdaq grants Biomerica an additional 180 days to meet listing compliance requirements - The Manila Times
Biomerica granted extension to regain Nasdaq compliance - Investing.com India
Biomerica granted extension to regain Nasdaq compliance By Investing.com - Investing.com Canada
Biomerica Gains on IBS Announcement - Baystreet.ca
Biomerica Announces Direct-to-Consumer Availability of inFoods® IBS Test, Targeting Relief for Bloating and Gastrointestinal Pain - The Manila Times
Biomerica Reports First Quarter Fiscal 2025 Financial Results - The Manila Times
Japan Point of Care Test Market By Application - Third Eye News
Labcorp Expands Sexually Transmitted Infection (STI) Test Offerings with Rapid Syphilis Test - Quantisnow
Blood Testing Market Size, Growth, Opportunities 2024-2032 | - openPR
Blood Testing Instrument Market 2031 Research Report, Growth Trends And Competition | Genteel, Baxter, Danaher, Hologic, Biomerica, Meridian Bioscience, Abbott – Times-BD24 - Times-BD24
Blood Testing Market Reaches USD 169.15 Billion by 2032 Due - GlobeNewswire
Artificial intelligence: who are the leaders in personalized food recommendation for the consumer industry? - just-food.com
Short Interest in Biomerica, Inc. (NASDAQ:BMRA) Increases By 582.1% - Defense World
Industrial Microbiology Market Share and Size 2024 In The Latest Report - WhaTech
Short Interest in Biomea Fusion, Inc. (NASDAQ:BMEA) Expands By 7.8% - Defense World
Ra capital executives buy Bicara Therapeutics shares for $32.99m - Investing.com India
Bokf Na Acquires Shares of 375 BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) - Defense World
BioMarin Pharmaceutical (NASDAQ:BMRN) Price Target Cut to $115.00 by Analysts at Bank of America - Defense World
BioMarin price target lowered to $115 from $130 at BofA - TipRanks
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Shares Purchased by Acadian Asset Management LLC - Defense World
BioE3 Policy implementation and potential in Futuristic growth of J&K - Daily Excelsior
Nasdaq Gains 100 Points; Biomerica Shares Spike Higher - MSN
The United States Blood Testing Market Size & Outlook, 2030 - Grand View Research
Views of Wall Street’s Leading Experts on Biomerica Inc. - SETE News
Biomerica Inc. [BMRA] Stock trading around $0.38 per share: What’s Next? - The DBT News
BMRA’s 2023 Market Dance: Down -70.48% – Time to Invest? - The InvestChronicle
Saudi Arabia approves Biomerica's prostate cancer test - Investing.com
The Saudi Food and Drug Authority (SFDA) Approves Biomerica’s At Home PSA Screening Test to Detect Early Signs of Prostate Cancer - ForexTV.com
The Saudi Food and Drug Authority (SFDA) Approves Biomerica's At Home PSA Screening Test to Detect Early Signs of Prostate Cancer - StockTitan
Financial Metrics Exploration: Understanding Biomerica Inc. (BMRA) Through Ratios - The Dwinnex
Biomerica Full Year 2024 Earnings: US$0.35 loss per share (vs US$0.50 loss in FY 2023) - Yahoo Finance
Biomerica Reports Fiscal 2024 Year End Results - ForexTV.com
Biomerica (NASDAQ:BMRA) Stock Crosses Below 200-Day Moving Average of $0.66 - Defense World
Biomerica stock plunges to 52-week low of $0.28 - Investing.com India
Biomerica (NASDAQ:BMRA) Share Price Crosses Below 200 Day Moving Average of $0.76 - Defense World
Salmonella Testing Market Anticipated To Reach A CAGR Of 7.8% By 2031, Share, Size, Growth, Demand, And Seg... - WhaTech
Biomerica, Inc. (NASDAQ:BMRA) Short Interest Down 54.4% in June - Defense World
BMRABiomerica, Inc. Latest Stock News & Market Updates - StockTitan
Biomerica (NASDAQ:BMRA) Stock Passes Below 200-Day Moving Average of $0.83 - Defense World
Is Biomerica Inc. (BMRA) a good investment opportunity? – US Post News - US Post News
Financial Analysis: Biomerica Inc. (BMRA)'s Ratios Unveil Key Insights – DWinneX - The Dwinnex
Biomerica Launches At-Home Sample Collection for inFoods® IBS, Significantly Expanding Access for Millions of IBS Sufferers - StockTitan
Biomerica Launches At-Home Sample Collection for inFoods® IBS, Significantly Expanding Access for Millions of IBS ... - Afternoon Headlines
Biomerica (NASDAQ:BMRA) Stock Crosses Below Two Hundred Day Moving Average of $0.86 - Defense World
Biomerica Inc Azioni (BMRA) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):